Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOSUNETUZUMAB vs MULTIHANCE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOSUNETUZUMAB vs MULTIHANCE: Safety Overview

Metric MOSUNETUZUMAB MULTIHANCE
Total FAERS Reports 506 183
Deaths Reported 96 14
Death Rate 19.0% 7.7%
Hospitalizations 328 33
Average Patient Age 65.0 yrs 52.0 yrs
% Female Patients 43.7% N/A
Manufacturer Genentech, Inc. N/A
Route SUBCUTANEOUS N/A